Tekla Capital Management LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$3,046,273
+2.7%
67,7100.0%0.12%
+3.6%
Q4 2022$2,966,375
-47.2%
67,710
-39.1%
0.11%
-49.3%
Q2 2022$5,613,000
-9.7%
111,118
+14.3%
0.22%
+1.4%
Q1 2022$6,213,000
-42.4%
97,253
-20.7%
0.22%
-37.9%
Q2 2021$10,793,000
-9.5%
122,6990.0%0.35%
-14.4%
Q1 2021$11,930,000
-13.3%
122,6990.0%0.41%
-15.3%
Q4 2020$13,761,000
-12.7%
122,699
-27.8%
0.48%
-18.1%
Q3 2020$15,761,000
+70.9%
170,018
+43.8%
0.59%
+68.4%
Q2 2020$9,224,000
+13.2%
118,256
-15.1%
0.35%
-4.6%
Q1 2020$8,148,000
-13.0%
139,336
+19.2%
0.37%
+4.0%
Q4 2019$9,367,000
+26.3%
116,925
+15.9%
0.35%
+9.6%
Q3 2019$7,414,000
-17.2%
100,916
+6.3%
0.32%
-11.7%
Q2 2019$8,959,000
-3.3%
94,976
-17.9%
0.37%
-2.7%
Q1 2019$9,263,000
+37.2%
115,720
-7.6%
0.38%
+30.1%
Q4 2018$6,750,000
-40.8%
125,207
-14.2%
0.29%
-30.0%
Q3 2018$11,397,000
+23.0%
146,0010.0%0.41%
+17.3%
Q2 2018$9,268,000
+36.2%
146,001
+96.7%
0.35%
+32.8%
Q1 2018$6,806,00074,2210.26%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders